Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline

Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline

Objective To examine interactions between Neuropsychiatric symptoms (NPS) with Pittsburgh Compound B (PiB) and fluorodeoxyglucose positron emission tomography (FDG‐PET) in predicting cognitive trajectories. Methods We conducted a longitudinal study in the setting of the population‐based Mayo Clinic...

Full description

Bibliographic Details
Main Authors: Anna Pink, Janina Krell‐Roesch, Jeremy A. Syrjanen, Luke R. Christenson, Val J. Lowe, Prashanthi Vemuri, Julie A. Fields, Gorazd B. Stokin, Walter K. Kremers, Eugene L. Scharf, Clifford R. Jack Jr., David S. Knopman, Ronald C. Petersen, Maria Vassilaki, Yonas E. Geda
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Psychiatric Research and Clinical Practice
Online Access:https://doi.org/10.1176/appi.prcp.20220036

Internet

https://doi.org/10.1176/appi.prcp.20220036

Similar Items